Dr. Yves L'Epine, new CEO of the Guerbet Group
On October 17th, 2011, the Board of Directors of the Guerbet Group appointed Dr. Yves L’Epine as CEO. Mr. Jean-Jacques Bertrand, chairman of the Board of Directors was the temporary CEO during the transition time to recruit a new CEO following the sudden death of Mr. Bernard Massiot on May 28th, 2011. Yves L’Epine is 52 and has a former experience as interventional cardiologist. After a MBA programme at the INSEAD business school, he joined the pharmaceutical group Sandoz and went on occupying General Management positions at Novartis, Takeda and Abbott, mainly in France and in other countries in Europe. He will take up his position at Guerbet at the end of November 2011.